Category: Medicine

The US radiopharmaceuticals giant Lantheus is snapping up the Contract Development and Manufacturing (CDMO) Evergreen Theragnostics as it expands its…

Munich-based biotechnology company Ethris has announced encouraging topline data from a phase 1 clinical trial evaluating its lead messenger RNA…

Novo Nordisk has reported weight loss effects of up to 22% in patients who received a weekly subcutaneous dose of…

Head of solution value at One2Treat, Émilie Barré shares her journey to date with Outsourcing-Pharma. Could you give us an…

The round was led by the US venture capital (VC) firm General Catalyst Partners with participation from compatriot VC Greylock…

Compared to the previous years, 2024 has been a relatively slow year for mergers and acquisitions in the pharmaceutical space.…

Arctic Therapeutics announced this week that it has raised €26.5 million, a sum bankrolled by investors including the European Innovation…

Results from the STEP UP trial show that a high-dose formulation of Wegovy can significantly increase the weight loss effects…

Australian contract development and manufacturing organizations (CDMOs), BioCina and NovaCina, have merged in a move to pool their biologic and…

We ran a Q&A with John Clarke, associate director in patient recruitment at Innovaderm on the changing landscape of patient…

We ran a Q&A With Michael Young, co-founder of Lindus Health on the challenges of 2024 and the company’s goals…

Stakeholders across the clinical trials and digital health industry will be gathering next month in Orlando at the Summit for…

As pharmaceutical pipelines and R&D investments expand worldwide, the global market for clinical trials is projected to grow by almost…

Ashley Davidson, vice president of sponsor and tech strategy at Advarra, discusses her outlook for this year’s edition of the…

The evolution of clinical trials is being driven by an increased focus on patient perspectives and innovative statistical methodologies. Regulatory…

Johnson & Johnson has entered an acquisition agreement with drug developer Intra-Cellular Therapies priced at $14.6bn, positioning the deal as…

As the Cambridge Healthtech Institute (CHI) celebrates its 16th annual Clinical Ops Executives (SCOPE) Summit in Orlando, Florida, USA, next…

As India’s contract manufacturing and development organization (CDMO) is set to double in the next decade, Anthem Biosciences is planning…

The company’s launch is backed by an oversubscribed Series A round of $411m co-led by Forbion and General Atlantic. RA…

Denali Therapeutics has announced topline results from the phase 2/3 Healey ALS Platform Trial, which evaluated the effects of its…

Orbis was founded in 2021 by the Seeds Investment team of Novo Holdings, the assets and wealth manager of the…

Palatin Technologies has announced topline results for the phase 2b Breakout study, which evaluated the effects of bremelanotide in patients…

According to the terms of the deal, Gilead will select a set of drug targets and Terray will discover and…

Founded by a team of scientists and healthcare specialists in 2021, Nintx harnesses compounds from Brazil’s world-famous plant ecosystems to…

AbbVie and Nimble Therapeutics have announced an acquisition deal in which AbbVie will gain ownership of the company’s pipeline of…

The company creator General Inception (GI) has acquired Enable Medicine to pool its know-how regarding drug development and the biotech…

Noema Pharma has announced an extension of its series B financing round, bringing the total raised up to $147 million…

Shortly after acquiring a manufacturing site in Wisconsin, Eli Lilly intends to expand it to boost its production of injectable…

Pharma company, AbbVie, reports that its D1/D5 partial agonist, tavapadon, has met the primary and secondary endpoints in a pivotal…

PTC Therapeutics announced this week that it has made a deal with Novartis for global rights to its oral Huntington’s…

The pharma arm of Mitsubishi Chemical Group has launched a collaboration with US-based Dewpoint Therapeutics to co-develop a preclinical-stage treatment…

Investment in radiopharmaceuticals is ramping up as big pharma shows a growing appetite for this promising drug modality. Radiopharmaceuticals see…

The pharmaceutical business unit of the German giant Körber has snapped up the compatriot label and leaflet supplier Wilhelm Bähren…

Swiss oncology specialist Novocure has announced positive topline results from the PANOVA-3 phase 3 clinical trial, which evaluated the use…

While these sites are important for clinical research, they make patient recruitment challenging. Many participants are forced to travel to…

However, nonspecific binding (NSB) can hinder PK assays, impacting their accuracy and reliability. Fortunately, there are strategies and best practices…

Eli Lilly has released detailed results from the SURMOUNT-1 phase 3 trial, where over 1,000 obese or overweight prediabetic participants…

With around $2 billion of the investment dedicated to creating more than a thousand U.S. jobs, AstraZeneca is looking to…

AstraZeneca has reported positive results from the CAPItello-281 phase 3 trial, which evaluated Truqap (capivasertib) in combination with Johnson &…

The US company CervoMed announced yesterday that the FDA has granted Orphan Drug Designation to its oral investigational small molecule…

Spray drying involves converting pharmaceutical liquid solutions into tiny droplets that are rapidly dried with hot gases such as nitrogen.…

Founded in Munich in 2020, Adragos’ global manufacturing sites were acquired from other players including Haupt Pharma Livron, LAW Pharma,…

What’s new at leading trade publication Outsourcing Pharma

According to a recent report by Business Research Insights, the total size of the global decentralized clinical trials market was…

NVentures also participated in the company’s $200 million Series B last August.  This strengthened collaboration is aimed at advancing Genesis’…

eCOA and ePRO (electronic patient-reported outcome) technology are transforming clinical trials, offering streamlined processes for patients, sites, and sponsors. In…

C Ray Therapeutics has announced the completion of a series A+ financing round, which has exceeded the $100 million mark.…

Yesterday, Eli Lilly and Company revealed promising Phase 2 results for its investigational small molecule drug, Muvalaplin, against cardiovascular events.…

Now the Global market development manager at Phenomenex, she thrives on connecting insights with solutions, all while channeling the wisdom…

Now leading the Biopharma product management team at Phenomenex, she brings a problem-solving mindset honed by a love of forensic…

The global contract development and manufacturing organization (CDMO), Samsung Biologics, announced this week that it has entered into a collaboration…

Sameer Sabir, CEO and co-founder of Brixton Biosciences, aims to revolutionize pain management. With Neural Ice, the company’s groundbreaking drug-free…

The US big pharma company Pfizer has been granted marketing authorization for its hemophilia A and B treatment, HYMPAVZI (marstacimab),…

The phase 3 ICONIC-LEAD study showed that icotrokinra, a peptide drug that blocks the interleukin (IL)-23 receptor, was able to…

The phase 3 ICONIC-LEAD study showed​ that icotrokinra, a peptide drug that blocks the interleukin (IL)-23 receptor, was able to…

The US big pharma company Pfizer has been granted marketing authorization for its hemophilia A and B treatment, HYMPAVZI (marstacimab),…

C Ray Therapeutics has announced the completion of a series A+ financing round, which has exceeded the $100 million mark.…

Yesterday, Eli Lilly and Company revealed promising Phase 2 results for its investigational small molecule drug, Muvalaplin, against cardiovascular events.…

Under the terms of the merger agreement, Avid Bioservices will be acquired by funds managed by GHO and Ampersand in…

At the helm of Coronado’s scientific strategy, Professor Visser-Rogers envisions a data-driven future powered by innovative methodologies and emerging technologies.…

Gifthealth has announced a strategic partnership with United Digestive, a leading practice management organization for gastroenterology. This is to enhance…

Conducted with 136 US-based participants across multiple health conditions, the survey found that 63% said they would be more likely…

Medable, a provider of clinical development technology, has announced a collaboration with Google Cloud to bring its decentralized clinical trial…

However, nonspecific binding (NSB) can hinder PK assays, impacting their accuracy and reliability. Fortunately, there are strategies and best practices…

This forms part of an expanded partnership to enhance Genesis’ AI-powered drug discovery platform, GEMS (Genesis Exploration of Molecular Space).…

Eli Lilly has released detailed results from the SURMOUNT-1 phase 3 trial, where over 1,000 obese or overweight prediabetic participants…

With around $2 billion of the investment dedicated to creating more than a thousand U.S. jobs, AstraZeneca is looking to…

According to a recent report​ by Business Research Insights, the total size of the global decentralized clinical trials market was…

While these sites are important for clinical research, they make patient recruitment challenging. Many participants are forced to travel to…

According to the topline results, a total of 54% of patients given the treatment saw their tumors shrink compared to…

CEO Dexter Tjoa shares insights on the company’s journey, from early barcoding breakthroughs to embracing advanced technologies for patient safety,…

Epilepsy is one of the most common neurological conditions​ in the world, with around 50 million people with the condition.…

By offering comprehensive, integrated solutions, Abzena aims to streamline drug development processes and minimize risks for customers, helping to accelerate…

Tim Davis, vice president of strategy at Veeva eCOA, had a conversation with Outsourcing Pharma’s senior editor, Liza Laws, and…

Ascendis Pharma has granted Novo Nordisk an exclusive worldwide license to its TransCon technology platform for the development, manufacturing and…

Silmitasertib, also known as CX-4945, was originally developed by Cylene Pharmaceuticals, a San Diego-based biotech that ceased operations in 2013.…

The Palomar Health Foundation recently completed its third annual Middle School Medical Discoveries (Middle School MD) program, engaging local youth…

Starget Pharma, an Israeli startup developing AI-powered precision therapies for difficult-to-treat cancers, has secured a $5.1 million investment from MD…

Novo Nordisk has released data from the SELECT phase 3 trial showing that a 2.4 mg dose of semaglutide reduced…

Novartis’ Scemblix (asciminib) has received accelerated approval by the US FDA as a treatment for adult patients with newly diagnosed…

A new case study from AllazoHealth demonstrates that a top 10 rare disease pharmaceutical company experienced a 10.4% increase in…

This integration aims to create a unified lab management experience, offering scientists enhanced data traceability, security, and streamlined workflows across…

In an exclusive interview, Vicky shares insights on her career, the challenges she faced, and her passion for inspiring the…

From reducing operational costs to enhancing patient outcomes, Stevanato Group is at the forefront of digital transformation in pharma. Digital…

Since the FDA approval of Novo Nordisk’s Wegovy as a treatment for chronic weight management in 2021, followed by the…

Epilepsy is one of the most common neurological conditions​ in the world, with around 50 million people with the condition.…

With a background spanning biotech and executive roles at Medtronic, Anu brings a unique blend of resilience, collaboration, and strategic…

This alliance marks a shift in biopharma R&D, with the launch of the Biophysics Institute for Biomedical Research (IBRB), offering…

Rentschler Biopharma, a global contract development and manufacturing organization (CDMO) will be increasing its production at its headquarters in Laupheim…

GSK is one of the world’s biggest pharmaceutical companies with products ranging from the shingles vaccine Shingrix and the HIV…

Modifi Biosciences, a spin out of Yale University founded in 2021, has been snapped up by Merck for $30 million…

Radiopharmaceuticals consist of radioactive isotopes that are chemically attached to small molecules, peptides or protein drugs such as antibodies. These…

Modifi Biosciences, a spin out of Yale University founded in 2021, has been snapped up by Merck for $30 million…

Radiopharmaceuticals consist of radioactive isotopes that are chemically attached to small molecules, peptides or protein drugs such as antibodies. These…

The EU first gave Translarna a conditional marketing authorization in 2014 for the treatment of DMD, a progressive condition that…

A new Alzheimer’s treatment, donanemab, has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA), but a draft…

Seaport has developed a platform called Glyph designed to enhance efficacy and reduce the side effects of potential drug candidates.…

The EU first gave Translarna a conditional marketing authorization in 2014 for the treatment of DMD, a progressive condition that…

Lundbeck and Longboard Pharmaceuticals have announced an agreement for the Danish pharmaceutical company to acquire all outstanding shares of Longboard,…

Techbio is a field where the computational expertise of the tech sector and the biological know-how of the biotech sector…

Find out all about her intriguing journey to where she is now in her role as marketing manager within small…

With a career spanning monoclonal antibodies and now cell therapies, she expertly navigates complex regulatory landscapes to bring life-changing treatments…

Outsourcing Pharma caught up with experts from the global CDMO, CordenPharma, to learn how they maintain their competitive edge. Brittany…

The K2 trial tested oditrasertib’s safety and ability to reduce the blood levels of neurofilament light chain, a biomarker of…

With a background in pharmacy and specialized pediatric care, she now bridges bioinformatics with practical, user-friendly tools, empowering clinicians to…

Now a global market development manager, she plays a pivotal role in shaping solutions for food safety and environmental protection.…

The significant advantages it offers include: Large reduction in COGS: By 2025, EnzeneX 2.0 expects to produce 40 kg/1000 L…

These siliconized vials are designed to protect sensitive, aggressive, and viscous drug products by reducing interactions with the glass and…

Danish techbio company Evaxion Biotech has published results showing the outcome of three clinical trials comparing the prediction scores of…

Dyslipidemia, a condition involving unhealthy levels of cholesterols and other fats in the blood, is a major risk factor in…

Antag Therapeutics has announced that the FDA has accepted the investigational new drug (IND) application for its lead drug candidate,…

One area it is thriving is pharmaceuticals as it is being used to bring drugs to market faster than ever…

But what does the Act mean for the biotech and pharma industry and how can companies best prepare for any…

Innovent Biologics and Jiangsu Aosaikang Pharmaceutical (Ask Pharm) have announced a strategic collaboration regarding limertinib, a third-generation epidermal growth factor…

One of Recipharm’s main aims is the expansion of its oral solid dosage and sterile fill & finish services in…

Located at booth 3B25 (API Hall 3), the company says it will demonstrate its ongoing commitment to advancing the global…

We also delve into the latest trends, the rise of AI and the increasing focus on sustainability. How has the…

He will also be explaining how the company is expanding its Translational Pharmaceutics platform into new therapeutic areas like mRNA,…

The event provides a great platform for the company to present its newest addition—a 20,000 sq ft facility in Stirling,…

The company explains attendees will gain insight into how Ardena’s innovations can streamline drug development for advanced therapies, particularly in…

The success of these trials hinges on finding and enrolling the right patients in a timely manner. Eben Scanlon, chief…

The company says this new platform is specifically designed to administer large-volume injectable therapies, including highly viscous biological drugs, making…

Find out all about her intriguing journey to where she is now in her role as marketing manager within small…

The expansion involves setting up a new facility, which is planned to begin operations in late 2026. The facility, which…

UK-based company LoQus23 Therapeutics has announced the closing of a £35 million series A round to advance its pipeline of…

Sequentia will use the round winnings to speed up the market introduction of its cloud-based and microbiome-focused healthcare software MICK…

Eric Prugh is the chief product officer at Authenticx, a US-based company that recently launched an AI solution to detect…

With a passion for problem-solving and sustainability, her journey into science began with a fascination for philosophy and the origins…

The withdrawal decision was prompted by clinical data indicating that the overall benefit of Oxbryta “no longer outweighs the risk”…

The oral, specific dopamine agonist met its primary endpoint in the trial, which is the second of three phase 3…

Biohaven, which spun out​ of Biohaven Pharmaceuticals in 2022 when its parent company was acquired by Pfizer, has had a…

NPC is a progressive disease where the patient has a mutation in NPC1 or NPC2 – genes that are involved…

Nura Bio has announced the addition of $68 million to its series A financing, closing the round with a total…

Insilico Medicine, a biotech company with offices in both China and the US, announced this week that its lead candidate…

She brings her global experience across multiple therapeutic areas to her current role leading operations at YPrime. In this position,…

As the premier sponsor, CluePoints is helping to elevate RBQMLive as the industry’s leading event focused on the evolving field…

Infections caused by Aspergillus species of mold are transmitted through inhalation and can lead to symptoms including hypersensitivity reactions and…

Boehringer Ingelheim reported​ this week that its phase 3 Fibroneer-IPF trial had met its primary endpoint of an improvement in…

Announced on September 4, 2024, this acquisition positions uMotif to enhance its existing capabilities by integrating ClinOne’s enterprise consent management,…

She is CEO of Vaxess and wants to be able to deliver therapeutics in the most patient-friendly and pain-free way.…

The four-year extension focuses heavily on enhancing data management in oncology research, allowing EORTC to streamline patient access to clinical…

The company’s latest offering empowers clinical trial sponsors to harness the full potential of their biospecimen data, transforming it into…

The company says this new data and analytics management solution marks a significant shift in how medical affairs professionals can…

The tool supports critical RBQM processes like risk assessment, central monitoring, issue management, risk reassessment, targeted site monitoring, and KRI…

Leslie Pascaud, chief marketing officer at ObvioHealth, believes the key to effective marketing remains grounded in three fundamentals: a compelling…

In this Q&A, Dr Fabrice Chartier (FC), CEO of Simbec-Orion and Joern Klinger (JK), CEO of biotx.ai explore AI-enabled causal…

The report, called ‘The strategic allocation of opioid settlement funds – an evidence-based approach to preventing deaths from opioid use…

Ravi Karra, VP of Oncology at the service provider Advanced Clinical, explains how advanced imaging techniques and trial designs can…

Read our interview to discover how losing her beloved horse ended her desire to be a vet to her belief…

This patent protects the company’s proprietary Creyon platform, which rapidly engineers and optimizes OBMs, marking a significant advancement in the…

A new report from the Access to Medicine Foundation takes a groundbreaking look at how some of the largest pharmaceutical…

With a passion for science and an ‘eternal technology optimist’, she says playing a role in getting patients they need…

This collaboration, the healthcare technology companies say, promises to streamline clinical trial recruitment and optimize long-term patient engagement. “This partnership…

The connector seamlessly integrates LabWare’s Laboratory Information Management System (LIMS) and Electronic Lab Notebook (ELN) with Mettler Toledo’s LabX software,…

Kizewski delves into how SOMS is changing trial design, optimizing patient safety, and enhancing the chances of FDA approval, providing…

The collaboration between ALZpath and Beckman Coulter marks a significant step toward making early detection more accessible and less invasive.…

The partnership aims to enhance access to clinical trials for patients suffering from pancreatic cancer by leveraging myTomorrows’ extensive database…

As head of platform development at Empress Therapeutics, Thompson uses her expertise to advance the company’s Chemilogics platform. This platform…

This collaboration, which began in 2023, has significantly enhanced patient outcomes and healthcare efficiency through a hybrid model integrating digital,…

Mpox is a viral infection​ with symptoms including rash and fever, and spreads through contact with body fluids, skin lesions…

As the senior director and general manager of pharma (Cryo-EM), Melanie is not only pioneering the use of technology to…

The tool, aimed at research use only (RUO), promises to significantly improve early diagnostic capabilities in these areas. XpressGT: A…

Results from a phase 2 trial of the candidate schizophrenia drug, currently known as NBI-1117568, show that it met the primary…

The company, focused on solutions for severe allergic reactions was granted the approval last week, on August 22. This marks…

This approval marks the first pan-FGFR kinase inhibitor approved in the European Economic Area for this indication, providing a significant…

The first patient has been dosed, marking a significant step in addressing the needs of a patient population that currently…

The collaboration between ALZpath and Beckman Coulter marks a significant step toward making early detection more accessible and less invasive.…

The ongoing study, conducted at the Scientia Clinical Research facility in Sydney, Australia, is focused on evaluating the safety, tolerability,…

This collaboration builds on the success of H1’s earlier efforts in the Middle East following the Hamas attacks on October…

This marks a significant milestone as Otezla is the first FDA-approved oral medication for children and adolescents in this category.…

This marks a significant milestone as Otezla is the first FDA-approved oral medication for children and adolescents in this category.…

As the senior director and general manager of pharma (Cryo-EM), Melanie is not only pioneering the use of technology to…

This collaboration builds on the success of H1’s earlier efforts in the Middle East following the Hamas attacks on October…

Her journey, shaped by early experiences with illness in her family, has fueled Elaine’s commitment to advancing patient-centric technologies. At…

This exceptional performance underscores the profound impact Ayvakit is having on patients with systemic mastocytosis (SM), a rare and debilitating…

Mpox is a viral infection​ with symptoms including rash and fever, and spreads through contact with body fluids, skin lesions…

This approval is particularly significant for patients who have had an inadequate response to ursodeoxycholic acid (UDCA), the current standard…

At the helm of innovation in this domain is Stefan Duerr, the senior director of product management and client delivery…

Through innovative platforms like UniSecure and UniTrace, Systech ensures unparalleled transparency, security, and compliance across global pharmaceutical supply chains. These…

The company also optimizes routes and ensures compliance with stringent industry regulations. Guru Rao, CEO of nuVizz, chats to OSP and provides…

With regulations like the Drug Supply Chain Security Act (DSCSA) in the United States and the European Union Medical Device…

This collaboration seeks to address some of the most pressing challenges in healthcare, including compliance with the Drug Supply Chain…

The collaboration is set to revolutionize the healthcare supply chain by increasing the compatibility between RFID (radio frequency identification)-tagged medications…

The news was shared at at the International Association for the Study of Pain (IASP) 2024 World Congress on Pain in…

She obtained a PhD in experimental pathology from Lund University, and subsequently completed a postdoctoral fellowship on the molecular mechanisms…

The upgrade includes the installation of advanced bottling and labeling equipment, aimed at enhancing early-phase clinical manufacturing services. This development…

The funds will be deployed to expand its operations across the US and Europe, with a particular focus on enhancing…

This marks the first significant innovation in epinephrine delivery in more than 35 years and offers an alternative to the…

Her journey, shaped by early experiences with illness in her family, has fueled Elaine’s commitment to advancing patient-centric technologies. At…

To gain a deeper understanding of this complex landscape, OSP sat down with three industry experts from CluePoints: Francois Torche,…

PhaseV, under the leadership of CEO Raviv Pryluk, stands at the forefront of this transformation. In this interview, Pryluk shares…

The FDA has determined that the drug, aimed at treating PTSD, cannot be approved without further data and has requested…

This decision follows a mixed response from the FDA advisory committee, which voted against recommending the treatment. However, the need…

Patel delves into the intricacies of equipment lifespan, cost management, downtime impact, and the importance of predictive maintenance, offering practical…

As part of this alliance, Bruker has acquired a minority stake in NovAliX, and says this highlights the increasing importance…

Outsourcing Pharma had the opportunity to speak with Kazu Okuda, MD, CEO, and co-founder of Universal Brain, about the advancements…

Finding herself on a pediatric ward something inside her changed and she became determined to do something to help the…

As Skye embarks on their CBeyond phase 2 clinical trial, we explore the motivation, methodology, and expected outcomes of incorporating…

Backed by a $55 million Series A funding round from Apple Tree Partners (ATP) and a contract with the Biomedical…

This decision follows a mixed response from the FDA advisory committee, which voted against recommending the treatment. However, the need…